Does Migraine Cause Raised Intracranial Pressure?
No, migraine itself does not cause raised intracranial pressure (ICP), but these are distinct conditions that can coexist and may be easily confused clinically.
Key Distinction Between Migraine and Raised ICP
Migraine and idiopathic intracranial hypertension (IIH) are separate disease entities with different underlying pathophysiology. However, the clinical overlap creates significant diagnostic challenges:
- Migraine is a primary headache disorder with normal ICP
- IIH is a condition of pathologically elevated ICP that can present with migraine-like headache features 1
The Critical Clinical Overlap
The 2018 IIH consensus guidelines explicitly recognize that "patients with IIH often have coexisting migrainous headaches superimposed on the headaches secondary to raised intracranial pressure" 1. This creates a complex clinical scenario where:
- Both conditions share similar headache phenotypes (throbbing pain, photophobia, phonophobia, nausea) 1
- Both respond to topiramate 1
- Both are more common in women and associated with obesity 2
- Both can present with allodynic symptoms 2
The Misdiagnosis Problem
IIH without papilledema (IIHWOP) is frequently misdiagnosed as chronic migraine, with studies showing:
- Up to 14% of chronic migraine clinical series actually have IIHWOP 2
- In patients with refractory chronic migraine and sinus stenosis, 86.4% had elevated opening pressure >200 mmH₂O 3
- 70.5% of these patients fulfilled ICHD-II criteria for "Headache attributed to Intracranial Hypertension" despite lacking papilledema 3
Red Flags Suggesting Raised ICP Rather Than Migraine
The 2021 Nature Reviews Neurology guideline provides specific red flags to identify secondary headaches 4:
- Progressive headache (suggests intracranial space-occupying lesion)
- Headache aggravated by postures or maneuvers that raise intracranial pressure
- Headache brought on by sneezing, coughing, or exercise
- New onset after age 50
- Associated weight loss, memory changes, or personality changes
When to Suspect IIHWOP in "Migraine" Patients
Consider lumbar puncture with opening pressure measurement in patients with 1, 2, 3:
- Almost daily or near-daily headache (chronic migraine pattern)
- Refractoriness to multiple preventive treatments
- Evidence of venous sinus stenosis on neuroimaging
- Postural component to headache
The IIH guidelines emphasize that "failure to optimize the ICP may render the migrainous headache difficult to treat" 1.
Diagnostic Approach
When raised ICP is suspected:
- Lumbar puncture with opening pressure measurement is essential 1
- Opening pressure >250 mmH₂O is clearly elevated
- Opening pressure 200-250 mmH₂O is borderline and requires clinical correlation 1
- Absence of papilledema does NOT exclude raised ICP 2, 3
Treatment Implications
The distinction matters because:
- Serial lumbar punctures are not recommended for IIH management 1
- However, a single therapeutic LP with CSF withdrawal resulted in sustained remission in 77.3% of patients with refractory chronic headache and elevated ICP, with 54.6% maintaining episodic headache pattern at 2 months 3
- Acetazolamide has not been shown effective for headache alone in IIH 1
- Standard migraine preventives may fail if underlying elevated ICP is not addressed 1
Important Caveats
- The normal range of CSF opening pressure remains controversial 5
- Some asymptomatic individuals may have elevated ICP without symptoms 2
- Normalization of ICP does not always translate to headache improvement 5
- The relationship may be bidirectional: elevated ICP may contribute to migraine chronification in predisposed individuals 2
Bottom Line for Clinical Practice
Migraine does not cause raised ICP, but raised ICP can masquerade as chronic migraine. Consider IIHWOP in any patient diagnosed with chronic migraine who fails multiple preventive treatments, especially if they have venous sinus stenosis on imaging. These patients require lumbar puncture with opening pressure measurement, as they may have a treatable cause of their refractory headache that will not respond to standard migraine therapies alone.